Cargando…
GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism()
Guanosine triphosphate binding protein 4 (GTPBP4) is a key regulator of cell cycle progression and MAPK activation. However, how its biological properties intersect with cellular metabolism in hepatocellular carcinoma (HCC) development remains poorly unexplained. Here, high GTPBP4 expression is foun...
Autores principales: | Zhou, Qiang, Yin, Yirui, Yu, Mincheng, Gao, Dongmei, Sun, Jialei, Yang, Zhangfu, Weng, Jialei, Chen, Wanyong, Atyah, Manar, Shen, Yinghao, Ye, Qinghai, Li, Chia-Wei, Hung, Mien-Chie, Dong, Qiongzhu, Zhou, Chenhao, Ren, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483790/ https://www.ncbi.nlm.nih.gov/pubmed/36116159 http://dx.doi.org/10.1016/j.redox.2022.102458 |
Ejemplares similares
-
Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma
por: Weng, Jialei, et al.
Publicado: (2021) -
Low expression of WW domain‐containing oxidoreductase associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection
por: Zhou, Chenhao, et al.
Publicado: (2018) -
Development and validation of a nomogram combining hematological and imaging features for preoperative prediction of microvascular invasion in hepatocellular carcinoma patients
por: Zhou, Qiang, et al.
Publicado: (2021) -
The Age-Specific Features and Clinical Significance of NRF2 and MAPK10 Expression in HCC Patients
por: Atyah, Manar, et al.
Publicado: (2022) -
SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway
por: Zhou, Chenhao, et al.
Publicado: (2020)